I see a path to strong business growth but only moderate equity compounding. Demand for AI optics looks real, Lumentum has visible manufacturing and
qualification advantages, and new capacity plus vertical integration can lift revenue materially. But the stock already trades like a strategic choke point, so most of the next five years likely comes from execution and earnings quality rather than another huge
rerating.